BioNTech Completes Acquisition of Biotheus

Read more

Purple Biotech Partners with Mount Sinai for CAPTN-3 Tri-Specific Antibody Research

Read more

Imfinzi Recommended for EU Approval as First Immunotherapy for Limited-Stage Small Cell Lung Cancer

Read more

Pfizer’s BRAFTOVI Combo Boosts Survival in Phase 3 BREAKWATER Trial

Read more

Vertex Announces FDA Approval of First-in-Class Pain Treatment JOURNAVX for Adults

Read more

Sarclisa Approved in China as First Anti-CD38 Treatment for Newly Diagnosed Multiple Myeloma

Read more

Kazia Therapeutics Launches Groundbreaking Trial of Paxalisib and Immunotherapy for Advanced Breast Cancer

Read more

Orion and Invenra Partner to Develop Bispecific Antibody Cancer Therapies

Read more

ImmunityBio Partners with BeiGene on Phase 3 Trial for ANKTIVA and PD-1 Combo in NSCLC

Read more

European Commission Approves ViiV’s Vocabria + Rekambys for HIV Treatment in Adolescents

Read more